Navigation Links
Hospira Launches Generic Irinotecan Injection
Date:2/27/2008

rs, and many of these compounds are in Hospira's robust product pipeline. To help reduce medication errors, Hospira labels all of its injectable products with unit-of-use bar codes.

Hospira already markets irinotecan in Canada, Australia and several European countries.

Indications and Safety Information

Irinotecan hydrochloride injection is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. Common adverse events include diarrhea (early and late), neutropenia, leukopenia, anemia, thrombocytopenia, nausea, vomiting, abdominal cramping, cholinergic symptoms, dizziness, visual disturbances, alopecia, mucositis, pain, weakness and fever.

Boxed Warning: Irinotecan HCl Injection should be administered only under the supervision of a physician who is experienced in the use of cancer chemotherapeutic agents. Appropriate management of complications is possible only when adequate diagnostic and treatment facilities are readily available. Irinotecan HCl Injection can induce both early and late forms of diarrhea that appear to be mediated by different mechanisms. Both forms of diarrhea may be severe. Early diarrhea (occurring during or shortly after infusion of Irinotecan HCl Injection may be accompanied by cholinergic symptoms of rhinitis, increased salivation, miosis, lacrimation, diaphoresis, flushing, and intestinal hyperperistalsis that can cause abdominal cramping. Early diarrhea and other cholinergic symptoms may be prevented or ameliorated by atropine (see PRECAUTIONS, General). Late diarrhea (generally occurring more than 24 hours after administration of Irinotecan HCl Injection) can be life threatening since it may be prolonged and may lead to dehydration, electrolyte imbalance, or sepsis. Late diarrhea should be treated promptly with loperamide. Patients with diarrhea should be carefully monitored and given fluid and electrolyte repla
'/>"/>

SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
2. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
3. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
4. Hospira Reports Third-Quarter 2007 Results
5. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
6. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
7. eDiets(R) Launches Fresh Meal Delivery Program for alli(R) Users
8. AthletixNation.com Launches Sports Website and Community Programs
9. ARJO, Inc. Launches Two Innovative Products and New Campaign
10. Specialty European Pharma launches plenaxis in Germany
11. GO3 Launches Line of Health-Focused Products with Partner David Beckham
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... -- The world is less than 40 years away ... for people and governments, according to a top scientist ... first time in human history, food production will be ... land, water and energy," said Dr. Fred Davies, senior ... "Food issues could become as politically destabilizing by 2050 ...
(Date:4/17/2014)... 17, 2014While 94 per cent of Canadians surveyed said ... newborns for a specific number of genetic conditions, only ... participate in screening that would sequence their newborns, genomes.,Most ... in their first day or two of life in ... their heels and tested for about five to 54 ...
(Date:4/17/2014)... Vice-Chancellor, Professor Patrick Johnston, whose work has transformed cancer ... Fellow of the European Academy of Cancer Sciences., The ... advisory body of highly distinguished oncologists and cancer researchers ... by cancer in Europe. , Professor Johnston, whose leadership ... from the bottom of the UK league table to ...
(Date:4/17/2014)... from LSTM have called for more research to ... in children in sub-Saharan Africa. In a paper ... Professor Russell Stothard, working with colleagues in the ... Reserve University, in Cleveland Ohio, University of Cambridge ... research into the joint burden of HIV/AIDS and ...
(Date:4/16/2014)... April 15, 2014 The Translational Genomics Research ... their annual Founders Dinner for their support of TGen,s ... took place March 28 in Scottsdale. , Catherine Ivy, ... Foundation, received TGen,s John S. McCain Leadership Award, named ...
Breaking Medicine News(10 mins):Health News:Food shortages could be most critical world issue by mid-century 2Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3Health News:More research called for into HIV and schistosomiasis coinfection in African children 2Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2
... Minn., Sept. 13 Mayo Clinic,s,Multidisciplinary Simulation Center ... in the United States to be accredited by,the ... ACS positions,Mayo to offer and advance medical education ... team members, abilities to keep pace with,rapidly changing ...
... Twins and at Interlachen Country Club ... support for suicide prevention., MINNEAPOLIS, Sept. 13 ... Week,(September 9-15, 2007) this week with a special appearance ... the Hubert H. Humphrey Metrodome in,Minneapolis. SAVE is a ...
... White House Office of National Drug Control Policy to Include ... Ads as Part of New Anti-Methamphetamine Initiative, ... that its award-winning television advertisements have been,selected by the White ... a new national Meth prevention campaign. The Anti-Meth Campaign ...
... Calif., Sept. 13 Delphon Industries, based in,Hayward, ... its UltraTape division.,UltraTape Industries, of Salem, Oregon, is ... Delphon acquired UltraTape Industries on,June 20, 2007 to ... to provide unique materials and services to high ...
... Everett,s body temperature helped protect his spinal cord, doctors ... Buffalo Bills football player Kevin Everett was being rushed ... life-threatening spinal cord injury, he was already getting experimental ... Everett,s spinal cord was damaged in his neck as ...
... Goes Beyond Just Vitamins to Provide a Supplement for ... Joint Health, Company ... ... Joint Juice, Inc., the creator,of the original ready-to-drink glucosamine supplement, announced the launch,of the ...
Cached Medicine News:Health News:Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute 2Health News:Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute 3Health News:SAVE Recognizes National Suicide Prevention Week 2Health News:Meth Project Advertisements Selected for National Prevention Campaign 2Health News:Meth Project Advertisements Selected for National Prevention Campaign 3Health News:Novel Cooling Therapy May Have Aided Injured Football Player 2Health News:Novel Cooling Therapy May Have Aided Injured Football Player 3Health News:Novel Cooling Therapy May Have Aided Injured Football Player 4Health News:Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide 2
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... from MedImmune, PRINCETON, N.J., Aug. 12 ... its partner MedImmune, Inc. has,initiated a Phase 2A ... of systemic lupus erythematosus (SLE or lupus).,MEDI-545 is ... Human,Antibody Development System(R). Under the terms of the ...
... Therapeutics, Inc., a,privately held immunotherapeutics discovery and ... of novel immunotherapies for the,treatment of cancer, ... agreements with the Memorial Sloan-Kettering Cancer Center,s,Sloan-Kettering ... http://www.newscom.com/cgi-bin/prnh/20080812/LATU515LOGO ), The first license ...
Cached Medicine Technology:Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 3Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 4MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research 2
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
Inquire...
... BT table comes in two modelsthe BT4, ... the BT5, which offers five. With the ... adjust to suit your needs. Both ... controls, side rails, ankle/foot supports, adjustable arm ...
UROSKOP Access, the dedicated urodiagnostic table with truly unrestricted patient access optimizes nearly all diagnostic and interventional procedures....
Medicine Products: